Opportunistic Infections Citation List: July 31 - August 13, 2015
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
1. Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. Abdalla, M.Y., B.L. Switzer, C.H. Goss, M.L. Aitken, P.K. Singh, and B.E. Britigan. Antimicrobial Agents and Chemotherapy, 2015. 59(8): p. 4826-4834. PMID[26033732].
[PubMed]. OI_0731-081315.
2. Disulfiram and Copper Ions Kill Mycobacterium Tuberculosis in a Synergistic Manner. Dalecki, A.G., M. Haeili, S. Shah, A. Speer, M. Niederweis, O. Kutsch, and F. Wolschendorf. Antimicrobial Agents and Chemotherapy, 2015. 59(8): p. 4835-4844. PMID[26033731].
[PubMed]. OI_0731-081315.
3. Synthesis and Evaluation of Novel Fluorinated Pyrazolo-1,2,3-triazole Hybrids as Antimycobacterial Agents. Emmadi, N.R., C. Bingi, S.S. Kotapalli, R. Ummanni, J.B. Nanubolu, and K. Atmakur. Bioorganic & Medicinal Chemistry Letters, 2015. 25(15): p. 2918-2922. PMID[26048808].
[PubMed]. OI_0731-081315.
4. Ring-substituted 8-Hydroxyquinoline-2-carboxanilides as Potential Antimycobacterial Agents. Kos, J., I. Zadrazilova, E. Nevin, M. Soral, T. Gonec, P. Kollar, M. Oravec, A. Coffey, J. O'Mahony, T. Liptaj, K. Kralova, and J. Jampilek. Bioorganic & Medicinal Chemistry Letters, 2015. 23(15): p. 4188-4196. PMID[26183541].
[PubMed]. OI_0731-081315.
5. Chemical and Biological Metal Nanoparticles as Antimycobacterial Agents: A Comparative Study. Singh, R., L.U. Nawale, M. Arkile, U.U. Shedbalkar, S.A. Wadhwani, D. Sarkar, and B.A. Chopade. International Journal of Antimicrobial Agents, 2015. 46(2): p. 183-188. PMID[26009020].
[PubMed]. OI_0731-081315.
6. Evaluation of Macrolides for Possible Use against Multidrug-resistant Mycobacterium tuberculosis. van der Paardt, A.F., B. Wilffert, O.W. Akkerman, W.C. de Lange, D. van Soolingen, B. Sinha, T.S. van der Werf, J.G. Kosterink, and J.W. Alffenaar. European Respiratory Journal, 2015. 46(2): p. 444-455. PMID[26022960].
[PubMed]. OI_0731-081315.
Citations from the ISI Web of Knowledge Listings for O.I.
7. Discovery of Rimonabant and its Potential Analogues as anti-TB Drug Candidates. Gajbhiye, J.M., N.A. More, M.D. Patil, R. Ummanni, S.S. Kotapalli, P. Yogeeswari, D. Sriram, and V.H. Masand. Medicinal Chemistry Research, 2015. 24(7): p. 2960-2971. ISI[000357468200016].
[WOS]. OI_0731-081315.
8. Alkylamino Derivatives of N-Benzylpyrazine-2-carboxamide: Synthesis and Antimycobacterial Evaluation. Servusova-Vanaskova, B., O. Jandourek, P. Paterova, J. Kordulakova, M. Plevakova, V. Kubicek, R. Kucera, V. Garaj, L. Naesens, J. Kunes, M. Dolezal, and J. Zitko. MedChemComm, 2015. 6(7): p. 1311-1317. ISI[000357786200012].
[WOS]. OI_0731-081315.
9. Synthesis, Characterisation and Antitubercular Screening of 5(4H)-Oxazolone Derivatives. Suhasini, K.P., Y. Christopher, S.R.M. Rao, C.P. Kumar, and Y.L.N. Murthy. Journal of the Indian Chemical Society, 2015. 92(6): p. 951-955. ISI[000357762800032].
[WOS]. OI_0731-081315.
10. Whole Cell Screen Based Identification of Spiropiperidines with Potent Antitubercular Properties. Tantry, S.J., G. Degiacomi, S. Sharma, L.K. Jena, A. Narayan, S. Guptha, G. Shanbhag, S. Menasinakai, M. Mallya, D. Awasthy, G. Balakrishnan, P. Kaur, D. Bhattacharjee, C. Narayan, J. Reddy, C.N.N. Kumar, R. Shandil, F. Boldrin, M. Ventura, R. Manganelli, R.C. Hartkoorn, S.T. Cole, M. Panda, S.D. Markad, V. Ramachandran, S.R. Ghorpade, and N. Dinesh. Bioorganic & Medicinal Chemistry Letters, 2015. 25(16): p. 3234-3245. ISI[000357572000033].
[WOS]. OI_0731-081315.